Skip to main content
IMDX logo
IMDX
(NASDAQ)
Insight Molecular Diagnostics Inc.
$3.76-- (--)
Loading... - Market loading

Insight Molecular Diagnostics (IMDX) Stock Price & Financial Analysis

Insight Molecular Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.26 - $3.79
52-Week High$8.51
52-Week Low$2.33
Open$3.40
Volume292.77K
Average Volume (3M)292.77K
Market Cap120.44M
Shares Outstanding32.03M
Price to Sales (P/S)25.03
EV/EBITDA-1.62
Revenue (TTM)4.40M
Net Income (TTM)-60.78M
Free Cash Flow (TTM)-23.91M
EPS (TTM)$-1.90
Profit Margin-1380.69%
Operating Margin-590.28%
50-Day MA$5.45
200-Day MA$4.66
52-Week Change14.67%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Insight Molecular Diagnostics

What is the current stock price for IMDX?

As of the latest trading session, IMDX stock trades at $3.76. The 52-week range is $2.33–$8.51, with a day range of $3.26–$3.79.

What is the P/E ratio for IMDX?

The P/E ratio (Price-to-Earnings) for IMDX is shown in the Key Statistics section. This valuation metric helps compare Insight Molecular Diagnostics Inc. to industry peers.

Does IMDX pay dividends?

Insight Molecular Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMDX?

Based on 1 analyst, the consensus for IMDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMDX?

Insight Molecular Diagnostics's market capitalization is $120.4M, classifying it as a micro-cap company. Insight Molecular Diagnostics operates in the Healthcare sector within the Diagnostics & Research industry.